Tempest Therapeutics Inc banner

Tempest Therapeutics Inc
NASDAQ:TPST

Watchlist Manager
Tempest Therapeutics Inc Logo
Tempest Therapeutics Inc
NASDAQ:TPST
Watchlist
Price: 1.09 USD -1.8% Market Closed
Market Cap: $16.1m

Wall St Price Targets

TPST Price Targets Summary
Tempest Therapeutics Inc

There are no price targets for TPST.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Tempest Therapeutics Inc Competitors:
Price Targets
HCAT
Health Catalyst Inc
-7% Downside
SMCP
SMCP SA
76% Upside
NN
NextNav Inc
147% Upside
CDNA
CareDx Inc
-10% Downside
VRNS
Varonis Systems Inc
-13% Downside
AMAL
Amalgamated Bank
6% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TPST's stock price target?
Not Available

TPST does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett